Search Results

Is Your GPCR Program Slowing Down—Even With Good Data? You’re not alone. They stall because the data becomes a mess. GPCR Ecosystem. Strong science. Promising data. But no systems to turn it into momentum. GPCR, I’m connected to 1,300+ scientists and decision-makers worldwide. data chaos. ✅ Venture Capital Firms  – Looking to accelerate, troubleshoot, or validate GPCR assets

explicitly interested in GPCR signaling... but the thing about GPCRs... is you always kind of end up landing at a GPCR as a major target." GPCRs in the Background, But Always Present Even though his primary focus wasn’t GPCRs themselves, Serafini Takeaway Forget what you think you know about GPCR drug targets. data platform , GPCR training program , pain research , opioid signaling .

Welcome GPCR Fans,   In GPCR-targeted drug discovery, precision isn’t optional—it’s a requirement. But precision isn’t just about clean data; it’s about interpreting what that data means. GPCR Premium Members this week gain curated, early access to: Industry insights : GPCRs and mRNA in drug later in development In this exclusive session, Kenakin gives you the frameworks needed to interpret data GPCR Premium Membership Gives You an Edge Dr.

industry and the scientific community, with thousands of peer-reviewed publications and billions of data GPR75 MC4R NPY2R (PYY) SSTR5 Activins CALCR and RAMPs (AMYs) Apelin (APJ/AGTRL1) View representative data Together, these datasets exemplify the depth of pharmacological insight enabled by Eurofins DiscoverX platforms platform spanning the entire discovery and development continuum. These assays use the same platform as the Eurofins DiscoverX assays and beyond.

Sessions focus on scientific reasoning, data interpretation, and real discovery problems. Sam Hoare CRC Super-User: Your Data Advantage Kenneth A. platform to help train and inspire the next generation of scientists. About the GPCR Masterclass What is a GPCR Masterclass? Experts explain how they think about pharmacological data, experimental design, and discovery challenges—insight

pharmacology Data ❌ Suboptimal CRO Partnerships ❌ Stalled Pipeline Progression ❌ Uncertainty in GPCR to generate robust, decision-making data. Clear Platform Assessment: Gain rapid, independent insight into GPCR platform risks and true therapeutic assay platforms and in vitro models to deliver superior data quality and results. Biology-First, Data-Driven Solutions Every recommendation is rooted in GPCR biology, pharmacology experience